Evaluation of ACE2 and GlycACE2 expression levels showed a remarkably higher percentage of GlycACE2 expression in T2DM EMBs, whereas low levels of GlycACE2 were observed in the EMBs from non-T2DM patients (Fig. 5). This evidence concerns the gene ACE2 and type 2 diabetes mellitus.